1
Mahesh V Patel, Feng Jing Chen: Solid carriers for improved delivery of active ingredients in pharmaceutical compositions. Lipocine, Dianne E Reed, Reed & Associates, June 19, 2001: US06248363 (485 worldwide citation)

The present invention provides solid pharmaceutical compositions for improved delivery of a wide variety of pharmaceutical active ingredients contained therein or separately administered. In one embodiment, the solid pharmaceutical composition includes a solid carrier, the solid carrier including a ...


2
Mahesh V Patel, Feng Jing Chen: Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions. Lipocine, Dianne E Reed, Reed & Eberle, May 27, 2003: US06569463 (275 worldwide citation)

The present invention provides solid pharmaceutical compositions for improved delivery of a wide variety of pharmaceutical active ingredients contained therein or separately administered. In one embodiment, the solid pharmaceutical composition includes a solid carrier, the solid carrier including a ...


3
Mahesh V Patel, Feng Jing Chen: Solid carriers for improved delivery of active ingredients in pharmaceutical compositions. Lipocine, Thorpe North & Western, August 2, 2005: US06923988 (241 worldwide citation)

The present invention provides solid pharmaceutical compositions for improved delivery of a wide variety of pharmaceutical active ingredients contained therein or separately administered. In one embodiment, the solid pharmaceutical composition includes a solid carrier, the solid carrier including a ...


4
Lowey Hans, Stafford Herbert Henry: Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose. Forest Laboratories, March 11, 1975: US3870790 (135 worldwide citation)

A solid pharmaceutical composition in which the carrier consists essentially of hydroxypropylmethylcellulose, or hydroxypropylmethylcellulose admixed with up to about 20% ethylcellulose, is prepared by compressing a mixture comprising one therapeutic agent and the hydroxypropylmethylcellulose powder ...


5
Ubaldo Conte, Lauretta Maggi, Paolo Giunchedi: Multilayered controlled-release oral solid pharmaceutical forms. APR Applied Pharma Research, Nixon & Vanderhye, October 28, 1997: US05681583 (63 worldwide citation)

Multilayered controlled-release solid pharmaceutical composition in tablet form suitable for oral administration comprising at least two layers containing active material in association with excipients and additives. One layer of the tablet releases a portion of the drug quickly while the other laye ...


6
Jeffrey Owen Phillips: Substituted benzimidazole dosage forms and method of using same. The Curators of the University of Missouri, Joseph A Mahoney, Thomas R Stiebel, Mayer Brown Rowe & Maw, December 3, 2002: US06489346 (58 worldwide citation)

There is provided a solid pharmaceutical composition in a dosage form that is not enteric-coated, having active ingredients including a non-enteric coated proton pump inhibitor and at least one buffering agent. The proton pump inhibitor is omeprazole, lansoprazole, rabeprazole, esomeprazole, pantopr ...


7
Roland Cherif Cheikh: Sustained release of peptides from pharmaceutical compositions. Delab, Fish & Richardson P C, January 21, 1997: US05595760 (58 worldwide citation)

The invention features a method of administering a peptide to a patient and delivering the peptide continuously over an extended period of time of at least three days by obtaining a solid pharmaceutical composition including a soluble, gelable salt of the peptide and up to 30 percent, by weight, of ...


8
Bernard Charles Sherman: Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant. Bernard Charles Sherman, Ivor M Hughes, Neil H Hughes, Marcelo K Sarkis, March 6, 2001: US06197335 (51 worldwide citation)

A solid pharmaceutical composition for oral administration comprising a cyclosporin and an anionic surfactant, preferably sodium lauryl sulfate, wherein the amount of anionic surfactant is at least about forty percent of the minimum amount needed to dissolve the cyclosporin in water.


9
Rodney C Baker: Solid pharmaceutical composition. Coopers Animal Health, Nixon & Vanderhye, March 2, 1993: US05190760 (45 worldwide citation)

A solid pharmaceutical composition for release of a biologically active substance into a desired aqueous environment, containing a core and an outer layer, said core comprising between 17 and 93% by weight of the biologically active substance, between 0.01 and 7% by weight of a water swellable polym ...


10
Laman A Al Razzak, Kennan C Marsh, Richard A Pyter: Pharmaceutical composition. Abbott Laboratories, Steven R Crowley, September 24, 1996: US05559158 (44 worldwide citation)

A solid pharmaceutical composition is disclosed which comprises a pharmaceutically acceptable adsorbent or a mixture of pharmaceutically acceptable adsorbents to which is adsorbed a mixture of (1) a pharmaceutically acceptable organic solvent or a mixture of pharmaceutically acceptable organic solve ...



Click the thumbnails below to visualize the patent trend.